vs
BILL Holdings, Inc.（BILL）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
BILL Holdings, Inc.的季度营收约是Orthofix Medical Inc.的1.9倍（$414.7M vs $219.9M），BILL Holdings, Inc.净利率更高（-0.6% vs -1.0%，领先0.4%），BILL Holdings, Inc.同比增速更快（14.4% vs 2.0%），BILL Holdings, Inc.自由现金流更多（$103.8M vs $16.8M），过去两年BILL Holdings, Inc.的营收复合增速更高（13.3% vs 8.0%）
BILL Holdings, Inc. 是总部位于美国加利福尼亚州圣何塞的企业，专注为美国小型企业提供自动化云原生财务运营软件。旗下Bill.com Connect是白标端到端支付自动化平台，可供金融机构接入其单点登录的线上企业银行生态中使用。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
BILL vs OFIX — 直观对比
营收规模更大
BILL
是对方的1.9倍
$219.9M
营收增速更快
BILL
高出12.4%
2.0%
净利率更高
BILL
高出0.4%
-1.0%
自由现金流更多
BILL
多$87.0M
$16.8M
两年增速更快
BILL
近两年复合增速
8.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $414.7M | $219.9M |
| 净利润 | $-2.6M | $-2.2M |
| 毛利率 | 79.8% | 71.1% |
| 营业利润率 | -4.4% | 0.2% |
| 净利率 | -0.6% | -1.0% |
| 营收同比 | 14.4% | 2.0% |
| 净利润同比 | -107.7% | 92.4% |
| 每股收益（稀释后） | $-0.03 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BILLOFIX
| Q4 25 | $414.7M | $219.9M | ||
| Q3 25 | $395.7M | $205.6M | ||
| Q2 25 | $383.3M | $203.1M | ||
| Q1 25 | $358.2M | $193.6M | ||
| Q4 24 | $362.6M | $215.7M | ||
| Q3 24 | $358.4M | $196.6M | ||
| Q2 24 | $343.7M | $198.6M | ||
| Q1 24 | $323.0M | $188.6M |
净利润BILLOFIX
| Q4 25 | $-2.6M | $-2.2M | ||
| Q3 25 | $-3.0M | $-22.8M | ||
| Q2 25 | $-7.1M | $-14.1M | ||
| Q1 25 | $-11.6M | $-53.1M | ||
| Q4 24 | $33.5M | $-29.1M | ||
| Q3 24 | $8.9M | $-27.4M | ||
| Q2 24 | $7.6M | $-33.4M | ||
| Q1 24 | $31.8M | $-36.0M |
毛利率BILLOFIX
| Q4 25 | 79.8% | 71.1% | ||
| Q3 25 | 80.5% | 72.2% | ||
| Q2 25 | 80.8% | 68.7% | ||
| Q1 25 | 81.2% | 62.8% | ||
| Q4 24 | 81.6% | 69.0% | ||
| Q3 24 | 82.0% | 68.7% | ||
| Q2 24 | 81.0% | 67.8% | ||
| Q1 24 | 83.0% | 67.5% |
营业利润率BILLOFIX
| Q4 25 | -4.4% | 0.2% | ||
| Q3 25 | -5.2% | -8.3% | ||
| Q2 25 | -5.8% | -7.9% | ||
| Q1 25 | -8.1% | -25.2% | ||
| Q4 24 | -6.0% | -5.3% | ||
| Q3 24 | -2.1% | -9.6% | ||
| Q2 24 | -6.5% | -12.5% | ||
| Q1 24 | -8.6% | -15.6% |
净利率BILLOFIX
| Q4 25 | -0.6% | -1.0% | ||
| Q3 25 | -0.7% | -11.1% | ||
| Q2 25 | -1.8% | -6.9% | ||
| Q1 25 | -3.2% | -27.4% | ||
| Q4 24 | 9.3% | -13.5% | ||
| Q3 24 | 2.5% | -13.9% | ||
| Q2 24 | 2.2% | -16.8% | ||
| Q1 24 | 9.8% | -19.1% |
每股收益（稀释后）BILLOFIX
| Q4 25 | $-0.03 | $-0.05 | ||
| Q3 25 | $-0.03 | $-0.57 | ||
| Q2 25 | $0.02 | $-0.36 | ||
| Q1 25 | $-0.11 | $-1.35 | ||
| Q4 24 | $-0.06 | $-0.76 | ||
| Q3 24 | $0.08 | $-0.71 | ||
| Q2 24 | $0.37 | $-0.88 | ||
| Q1 24 | $0.00 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | $82.0M |
| 总债务越低越好 | $1.8B | — |
| 股东权益账面价值 | $3.8B | $450.0M |
| 总资产 | $10.1B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.48× | — |
8季度趋势，按日历期对齐
现金及短期投资BILLOFIX
| Q4 25 | $1.1B | $82.0M | ||
| Q3 25 | $1.1B | $62.9M | ||
| Q2 25 | $1.0B | $65.6M | ||
| Q1 25 | $1.0B | $58.0M | ||
| Q4 24 | $1.6B | $83.2M | ||
| Q3 24 | $853.5M | $30.1M | ||
| Q2 24 | $985.9M | $26.4M | ||
| Q1 24 | $952.5M | $27.0M |
总债务BILLOFIX
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.9B | $157.2M | ||
| Q2 25 | $1.7B | $157.0M | ||
| Q1 25 | $1.7B | $156.9M | ||
| Q4 24 | $1.7B | $157.0M | ||
| Q3 24 | $914.8M | $118.5M | ||
| Q2 24 | $914.0M | $118.0M | ||
| Q1 24 | $1.1B | $118.2M |
股东权益BILLOFIX
| Q4 25 | $3.8B | $450.0M | ||
| Q3 25 | $3.9B | $442.5M | ||
| Q2 25 | $3.9B | $458.3M | ||
| Q1 25 | $3.9B | $458.3M | ||
| Q4 24 | $3.8B | $503.1M | ||
| Q3 24 | $4.0B | $525.9M | ||
| Q2 24 | $4.1B | $546.0M | ||
| Q1 24 | $4.1B | $570.3M |
总资产BILLOFIX
| Q4 25 | $10.1B | $850.6M | ||
| Q3 25 | $10.2B | $832.6M | ||
| Q2 25 | $10.1B | $837.2M | ||
| Q1 25 | $9.6B | $823.1M | ||
| Q4 24 | $9.7B | $893.3M | ||
| Q3 24 | $9.0B | $867.9M | ||
| Q2 24 | $9.2B | $882.0M | ||
| Q1 24 | $9.1B | $906.0M |
负债/权益比BILLOFIX
| Q4 25 | 0.48× | — | ||
| Q3 25 | 0.48× | 0.36× | ||
| Q2 25 | 0.44× | 0.34× | ||
| Q1 25 | 0.43× | 0.34× | ||
| Q4 24 | 0.44× | 0.31× | ||
| Q3 24 | 0.23× | 0.23× | ||
| Q2 24 | 0.22× | 0.22× | ||
| Q1 24 | 0.28× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $105.3M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $103.8M | $16.8M |
| 自由现金流率自由现金流/营收 | 25.0% | 7.6% |
| 资本支出强度资本支出/营收 | 0.4% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $378.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流BILLOFIX
| Q4 25 | $105.3M | $27.7M | ||
| Q3 25 | $96.9M | $12.4M | ||
| Q2 25 | $83.8M | $11.6M | ||
| Q1 25 | $99.5M | $-18.4M | ||
| Q4 24 | $78.7M | $23.7M | ||
| Q3 24 | $88.6M | $11.7M | ||
| Q2 24 | $78.6M | $9.0M | ||
| Q1 24 | $66.8M | $-18.6M |
自由现金流BILLOFIX
| Q4 25 | $103.8M | $16.8M | ||
| Q3 25 | $95.6M | $2.5M | ||
| Q2 25 | $81.0M | $4.5M | ||
| Q1 25 | $98.4M | $-25.1M | ||
| Q4 24 | $78.3M | $15.2M | ||
| Q3 24 | $88.6M | $6.3M | ||
| Q2 24 | $78.4M | $-360.0K | ||
| Q1 24 | $66.8M | $-29.1M |
自由现金流率BILLOFIX
| Q4 25 | 25.0% | 7.6% | ||
| Q3 25 | 24.1% | 1.2% | ||
| Q2 25 | 21.1% | 2.2% | ||
| Q1 25 | 27.5% | -13.0% | ||
| Q4 24 | 21.6% | 7.0% | ||
| Q3 24 | 24.7% | 3.2% | ||
| Q2 24 | 22.8% | -0.2% | ||
| Q1 24 | 20.7% | -15.4% |
资本支出强度BILLOFIX
| Q4 25 | 0.4% | 4.9% | ||
| Q3 25 | 0.3% | 4.8% | ||
| Q2 25 | 0.7% | 3.5% | ||
| Q1 25 | 0.3% | 3.5% | ||
| Q4 24 | 0.1% | 4.0% | ||
| Q3 24 | 0.0% | 2.7% | ||
| Q2 24 | 0.1% | 4.7% | ||
| Q1 24 | 0.0% | 5.6% |
现金转化率BILLOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.35× | — | ||
| Q3 24 | 9.94× | — | ||
| Q2 24 | 10.35× | — | ||
| Q1 24 | 2.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BILL
| Accounts Payable And Accounts Receivable Solutions | $185.9M | 45% |
| Spend And Expense Interchange Revenue | $166.5M | 40% |
| Interest On Funds Held For Customers | $39.5M | 10% |
| Embedded And Other Solutions | $22.8M | 5% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
